The ability of miR-204 to target BDNF/TrkB and Ezrin, which have significant roles in normal cellular processes and are overexpressed in aggressive cancers, indicates that miR-204 may control key regulatory mechanisms, dysregulation of which can predispose normal developmental/differentiation events to undergo transformation. The gene discussed is EZR; the disease is cancer.